Ultragenyx Pharmaceutical Inc. RARE
$26.49
+0.42%
at last close
Financials (TTM)
- Revenue
- $717.21 million
- Net Income
- $-585,969,000
- Net Margin
- -81.70%
- Return on Equity
- 201.36%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -9.10
- Price / Sales
- 3.69
Over the trailing twelve months, Ultragenyx Pharmaceutical Inc. generated revenue of $717.21 million and net income of $-585,969,000, a net margin of -81.70%.
At the last closing price of $26.49, RARE trades at 3.69 times sales, with a market capitalization of $2.65 billion.
Key Stats
- Last Close
- $26.49
- Market Cap
- $2.65 billion
- 52-Week Range
- $18.29 – $39.89
- Average Volume
- 1.95 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.